Top Markets
#1 Pleasing Gold Pleasing Gold +1,501.47%
#2 Ontology Gas Ontology Gas +118.93%
#3 PulseChain PulseChain +58.72%
#4 Ontology Ontology +36.39%
#5 ConstitutionDAO ConstitutionDAO +31.37%
#6 BOOK OF MEME BOOK OF MEME +31.28%
#7 Neiro Neiro +28.33%
#8 Collect on Fanable Collect on Fanable +27.71%
#9 Pump.fun Pump.fun +23.59%
#10 Unit Pump Unit Pump +23.59%
Coin of the day
Pleasing Gold Pleasing Gold
設定
言語
日本
通貨
USD
テーマ
Icosavax, Inc. Icosavax, Inc.

Icosavax, Inc.

ICVX
株式のランク #25851
Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing... Icosavax, Inc. operates as a biopharmaceutical firm dedicated to developing immunizations against infectious diseases. Leveraging its proprietary virus-like particle (VLP) platform technology, the company primarily focuses its efforts on severe respiratory illnesses. Its developmental portfolio includes several key vaccine candidates: IVX-121, an RSV-targeted vaccine currently undergoing Phase 1/1b clinical trials; IVX-A12, a bivalent candidate designed to target both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV); IVX-241, a candidate specifically designed for hMPV; and IVX-411, a SARS-CoV-2 vaccine based on a receptor binding domain (RBD) sequence antigen, which is also in Phase 1/2 clinical trials. Established in 2017, Icosavax maintains its corporate headquarters in Seattle, Washington.
株価
$15.31
最終同期: 2024-02-29
時価総額
$45.70M
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Icosavax, Inc. (ICVX)

カテゴリー

Healthcare
Icosavax, Inc.（ICVX）のP/B比率
2026 時点のP/B比率 TTM: 0
Icosavax, Inc. の最新の財務報告および株価によると、現在のP/B比率（TTM）は 0 です。2026 年末時点でのP/B比率は 0 でした。
Icosavax, Inc. の P/B 比率の履歴（2026 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US